New drug tested for rare, painful fat disorder
NCT ID NCT05185843
Summary
This study is checking the long-term safety of an experimental drug called olezarsen for people with Familial Chylomicronemia Syndrome (FCS), a rare genetic disorder that causes extremely high fat levels in the blood and painful pancreas attacks. It is for 24 people who have already been treated with a similar drug called volanesorsen. Participants receive olezarsen as a shot every four weeks for up to four years to see how well their bodies tolerate it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAMILIAL CHYLOMICRONEMIA SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARC Biosystems, Clinical Assessment Unit (CAU)
Vancouver, British Columbia, V6Z 2C7, Canada
-
Centre Hospitalier Universite de Sherbrooke (CHUS)
Sherbrooke, Quebec, J1H 5N4, Canada
-
Centre for Heart Lung Innovation
Vancouver, British Columbia, V6Z 1Y6, Canada
-
Clinique des Maladies Lipidiques de Quebec Inc.
Québec, Quebec, G1V 4W2, Canada
-
Diabetes/Lipid Management & Research Center
Huntington Beach, California, 92648, United States
-
Ecogene-21
Chicoutimi, Quebec, G7H 7K9, Canada
-
Excel Medical Clinical Trials, LLC
Boca Raton, Florida, 33434, United States
-
Karolinska University Hospital Huddinge
Stockholm, 171 77, Sweden
-
St. Boniface General Hospital
Winnipeg, Manitoba, R2H 2Ab, Canada
-
University of Michigan, Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND)
Ann Arbor, Michigan, 48109-2800, United States
-
University of Rochester School of Medicine
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.